DBV Technologies | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amarin USD -25168000 24.64M 2024-09
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
DBV Technologies USD -30328000 3.51M 2024-09
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Incyte USD 301.51M 155.43M 2024-12
Insmed USD -230414000 16.98M 2024-12
Ionis Pharmaceuticals USD -110823000 37.83M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
PTC Therapeutics USD -62489000 7.98M 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12



DBV Technologies Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.